METAVIA INC (MTVA:NASDAQ)
$1.78 0.05 (2.8902%)
Analysed METAVIA INC (MTVA:NASDAQ) News Sources
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
08-06-2026
yahoo.com
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
09-06-2026
yahoo.com
Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream
10-06-2026
yahoo.com
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
17-06-2026
yahoo.com
MTVA: Vanoglipel and DA-1726 Data Presented at ADA 2026 Scientific Sessions
17-06-2026
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
23-06-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
26-06-2026
yahoo.com
OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz
30-06-2026
yahoo.com
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
09-07-2026
yahoo.com
Sector Update: Healthcare Stocks Softer Late Afternoon
09-07-2026
yahoo.com
What is the current price of METAVIA INC (MTVA:NASDAQ)?
The current price of METAVIA INC (MTVA:NASDAQ) is $1.78.
METAVIA INC (MTVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is $0.05.
METAVIA INC (MTVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is 2.8902%.
What is the most recent average sentiment score for METAVIA INC (MTVA:NASDAQ)?
The most recent average sentiment score for METAVIA INC (MTVA:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for METAVIA INC (MTVA:NASDAQ)?
The most recent sentiment for METAVIA INC (MTVA:NASDAQ) is .
SEC-8K** Filing Available For METAVIA INC (MTVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.